MOXICLOPRID Trademark

Trademark Overview

On Wednesday, May 18, 2022, a trademark application was filed for MOXICLOPRID with the United States Patent and Trademark Office. The USPTO has given the MOXICLOPRID trademark a serial number of 97416878. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Wednesday, May 7, 2025. This trademark is owned by BIMEDA Animal Health Limited. The MOXICLOPRID trademark is filed in the Pharmaceutical Products category with the following description:

veterinary pharmaceutical preparations for the control and treatment of internal parasites and external parasites
moxicloprid

General Information

Serial Number97416878
Word MarkMOXICLOPRID
Filing DateWednesday, May 18, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateWednesday, May 7, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 20, 2023

Trademark Statements

Goods and Servicesveterinary pharmaceutical preparations for the control and treatment of internal parasites and external parasites

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 24, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBIMEDA Animal Health Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDublin D18K8Y4
IE
Party NameBIMEDA Animal Health Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDublin D18K8Y4
IE

Trademark Events

Event DateEvent Description
Saturday, May 21, 2022NEW APPLICATION ENTERED
Saturday, November 5, 2022ASSIGNED TO EXAMINER
Tuesday, May 24, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, November 14, 2022NON-FINAL ACTION WRITTEN
Monday, November 14, 2022NON-FINAL ACTION E-MAILED
Monday, November 14, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, May 14, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, May 14, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 15, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 18, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 31, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 20, 2023PUBLISHED FOR OPPOSITION
Tuesday, June 20, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 15, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, February 15, 2024SOU EXTENSION 1 GRANTED
Thursday, February 15, 2024SOU TEAS EXTENSION RECEIVED
Thursday, July 25, 2024SOU TEAS EXTENSION RECEIVED
Thursday, July 25, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 25, 2024SOU EXTENSION 2 GRANTED
Thursday, February 15, 2024SOU EXTENSION 1 FILED
Friday, February 16, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 25, 2024SOU EXTENSION 2 FILED
Monday, February 3, 2025SOU EXTENSION 3 FILED
Monday, February 3, 2025SOU TEAS EXTENSION RECEIVED
Monday, May 5, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, May 7, 2025SOU EXTENSION 3 GRANTED
Wednesday, May 7, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

moxicloprid parasites internal external treatment control pharmaceutical preparations veterinary